Odyssey Health ODYY Income Statement (2014-2026)

OTC ODYY
$0.01 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Odyssey Health Quarterly Income Statement

Periods 48 quarters
Latest Apr 2026

Odyssey Health reported net income of $1.24M for the quarter ended Apr 2026. This income statement covers 48 quarters of results from Jul 2014 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Revenue & cost
Revenue
Cost of RevenueCost of Rev
Gross Profit
Operating items
Research & DevelopmentR&D
1.02M0.32M0.46M0.06M0.47M0.35M0.17M0.04M-0.19M0.02M0.04M-0.01M
Selling, General & AdministrativeSG&A
1.58M1.11M1.52M2.80M0.94M0.65M0.51M0.02M0.50M0.44M0.32M0.82M0.58M0.16M0.13M0.16M0.30M0.18M0.30M
Other Operating ExpensesOther Opex
-49.000.50M15.90M
Operating ExpensesOpex
2.61M1.43M1.98M2.87M0.47M1.30M0.82M0.54M-0.17M0.52M0.48M0.32M0.81M0.58M0.16M0.13M0.16M0.30M0.18M0.30M
Operating IncomeOp. Inc
-2.61M-1.43M-1.98M-2.87M-1.83M-2.08M-1.49M-1.09M-0.66M-0.35M-1.16M-0.37M0.24M-0.58M-0.16M-0.13M-0.16M-0.30M-0.18M-0.30M
EBIT
-2.61M-1.43M-1.98M-2.87M-1.83M-2.08M-1.49M-1.09M-0.66M-0.35M-1.16M-0.37M0.24M-0.58M-0.16M-0.13M-0.16M-0.30M-0.18M-0.30M
Non-operating items
Non Operating Interest Expenses
0.29M0.22M0.21M0.23M0.18M0.07M0.19M0.19M0.16M0.19M0.14M0.10M0.08M0.07M0.06M0.06M0.06M0.10M0.41M0.53M
Non Operating Investment IncomeNon-Op. Investment Inc.
-1.33M-0.37M0.06M-0.37M-0.06M-0.03M
Other Non Operating IncomeOther Non Op Inc.
0.49M-474.000.01M-79.00275.0065.000.01M186.00121.00-102.0064.00-0.01M0.42M-0.42M1.51M
Net income details
EBT
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Profit After TaxPAT
-2.90M-1.65M-1.69M-3.10M-2.01M-2.15M-1.67M-1.28M-0.81M-0.54M13.28M-0.84M-12.74M-1.02M-0.22M-0.25M-0.25M-0.48M-3.60M1.24M
Income from Continuing OperationsIncome (Continuing)
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Consolidated Net IncomeConsol Net Inc.
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Income towards Parent CompanyParent Net Inc
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.68M-1.28M-0.81M-0.54M-1.30M-0.47M0.15M-0.65M-0.22M-0.19M-0.21M-0.40M-0.59M-0.83M
Preferred Dividend PaymentsPref Dividends
0.06M
Net Income towards Common StockholdersNet Income
-2.90M-1.65M-2.18M-3.10M-2.01M-2.15M-1.67M-1.28M-0.81M-0.54M13.21M-0.84M-12.74M-0.65M-0.22M-0.25M-0.25M-0.40M-0.59M0.77M
Additional items
EPS (Basic)
-0.03-0.02-0.02-0.04-0.02-0.03-0.02-0.02-0.01-0.010.14-0.01-0.13-0.010.000.000.000.00-0.010.01
EPS (Diluted)
-0.03-0.02-0.02-0.04-0.02-0.03-0.02-0.02-0.01-0.010.12-0.01-0.13-0.010.000.000.000.00-0.010.00
Shares Outstanding
93.73M88.06M91.62M83.95M89.00M80.89M81.78M83.16M82.68M81.02M91.98M103.79M97.06M104.71M104.71M104.71M104.71M106.04M107.85M108.03M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
93.73M88.06M91.62M83.95M89.00M80.89M81.78M83.16M82.68M81.02M114.06M103.79M97.06M104.71M104.71M104.71M104.71M106.04M107.85M186.67M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
88.56M91.02M82.71M82.88M77.86M71.99M75.81M78.11M79.07M81.73M94.43M96.36M96.71M96.71M96.71M96.71M96.71M99.85M99.85M100.97M
EBITDA
-2.61M-1.43M-1.98M-2.87M-1.83M-2.08M-1.49M-1.09M-0.66M-0.35M-1.16M-0.37M0.24M-0.58M-0.16M-0.13M-0.16M-0.30M-0.18M-0.30M
Interest ExpensesInt Expense
0.29M0.22M0.21M0.23M0.18M0.07M0.19M0.19M0.16M0.19M0.14M0.10M0.08M0.07M0.06M0.06M0.06M0.10M0.41M0.53M